Suppr超能文献

硬化性黏液水肿:临床诊断与尸检结果

Scleromyxedema: clinical diagnosis and autopsy findings.

作者信息

Sala Ana Carolina Bulhões, Cunha Paulo Rowilson, Pinto Clóvis Antônio Lopes, Alves Célia Antônia Xavier de Moraes, Paiva Ingrid Barreto, Araujo Ana Paula Vieira

机构信息

Universidade Estadual de Campinas (UNICAMP) - Campinas (SP), Brazil.

Faculdade de Medicina de Jundiaí (FMJ) - Jundiaí (SP), Brazil.

出版信息

An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):48-50. doi: 10.1590/abd1806-4841.20164527.

Abstract

Scleromyxedema is a rare chronic cutaneous mucinosis of unknown etiology. It is characterized by papular eruption and scleroderma with microscopic evidence of mucin deposition, fibroblast proliferation, and fibrosis. Most patients with scleromyxedema have monoclonal gammopathy and systemic manifestations resulting in significant morbidity and mortality. Several types of treatment have been reported with partial or inconsistent responses. Despite showing unpredictable evolution, systemic consequences of scleromyxedema and treatment side effects may result in death. We describe a rare case of a patient with scleromyxedema without paraproteinemia with systemic involvement that evolved to death despite treatment with cyclophosphamide.

摘要

硬化性黏液水肿是一种病因不明的罕见慢性皮肤黏液水肿。其特征为丘疹性皮疹和硬皮病,并有黏液沉积、成纤维细胞增殖和纤维化的微观证据。大多数硬化性黏液水肿患者有单克隆丙种球蛋白病和全身表现,导致显著的发病率和死亡率。已有多种治疗方法的报道,但其反应部分或不一致。尽管硬化性黏液水肿的演变不可预测,但其全身后果和治疗副作用可能导致死亡。我们描述了一例罕见的硬化性黏液水肿患者,该患者无副蛋白血症但有全身受累,尽管接受了环磷酰胺治疗,病情仍发展至死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/5324991/6100f0e0c9fa/abd-91-05-s1-0048-g01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验